Detection and Quantification of FLT3 Internal Tandem Duplication Mutations Do Not Vary Significantly Between Whole Blood and Blast-Enriched Samples

Am J Clin Pathol. 2020 Jan 2;153(2):251-257. doi: 10.1093/ajcp/aqz166.

Abstract

Objectives: Many commonly used FLT3 mutational assay protocols require a tedious blast enrichment step. We investigated whether elimination of this step would still give equivalent results and compared the accuracy of variant allele fraction (VAF) between polymerase chain reaction/capillary electrophoresis (PCR/CE) vs next-generation sequencing (NGS) methods.

Methods: Total leukocyte vs blast-enriched whole-blood aliquots were tested for FLT3 internal tandem duplication (ITD) and tyrosine kinase domain mutations by PCR/CE. VAF of the ITD mutations was also compared with NGS VAF.

Results: Blast-enriched vs total leukocyte specimens showed 100% concordance in the 25 positive specimens. VAF was consistently lower by NGS, with poorer fidelity to PCR/CE VAF as the ITD size increased.

Conclusions: Our study supports elimination of the blast enrichment step without compromising results or sensitivity. In addition, since NGS shows a loose correlation with PCR/CE quantitative results, NGS VAF should not be reported for FLT3 ITDs.

Keywords: FLT3; Acute myeloid leukemia; Internal tandem duplication; Tyrosine kinase domain; Variant allele fraction.

MeSH terms

  • Alleles
  • Blast Crisis / genetics*
  • Electrophoresis, Capillary
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Mutation*
  • Polymerase Chain Reaction
  • Tandem Repeat Sequences*
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • fms-Like Tyrosine Kinase 3